Rezulin (troglitazone) for Type II diabetes
Rezulin (troglitazone) for Type II diabetes will be out soon. Parke-Davis is launching it this month in the U.S...possibly later this year in Canada.
This is the first drug in a new class...called "glitazones." These drugs are very useful...they reduce insulin resistance.
Troglitazone stimulates the uptake of glucose into skeletal muscle cells...and decreases glucose production in the liver.